Bistos Co., Ltd. (KOSDAQ:419540)
South Korea · Delayed Price · Currency is KRW 2,695.00
+185.00 (7.37%)
At close: Jul 31, 2026
Bistos Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 16,360 | 17,100 | 20,255 | 21,305 | 23,963 | 20,522 |
Revenue Growth | -9.87% | -15.58% | -4.93% | -11.09% | 16.77% | 13.87% |
Gross Profit Gross Profit Growth | 3,875 | 4,259 | 5,302 | 5,508 | 5,861 | 5,376 |
Operating Income Operating Income Growth | -909.08 | -1,096 | 311.42 | 283.82 | 912.89 | 1,592 |
Net Income Net Income Growth | -454.31 | -699.12 | 847.62 | 806.5 | -4,502 | 1,853 |
Earnings Per Share EPS Growth | -18.36 | -28.15 | 37.00 | 35.00 | -254.00 | 112.00 |
EPS Growth | - | - | 5.71% | - | - | 8.74% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Manufactured - Breast Pump Manufactured - Breast Pump Growth | 5,623 | 6,392 | 5,223 | 1,828 | 1,080 |
Manufactured - Fetal Monitors Manufactured - Fetal Monitors Growth | 3,842 | 3,354 | 3,109 | 3,570 | 2,287 |
Manufactured - Patient Monitoring Device Manufactured - Patient Monitoring Device Growth | 2,942 | 3,913 | 5,753 | 7,518 | 6,988 |
Manufactured - Incubator Manufactured - Incubator Growth | 2,209 | 1,907 | 2,648 | 1,244 | 1,455 |
Merchandised Merchandised Growth | 1,324 | 1,334 | 1,990 | 1,535 | 2,392 |
Manufactured - Fetal Heart Sound Measuring Instrument Manufactured - Fetal Heart Sound Measuring Instrument Growth | 1,124 | 1,310 | 1,783 | 1,653 | 1,345 |
Manufactured - Warmer Manufactured - Warmer Growth | 979 | 925.38 | 1,215 | 868 | 744 |
Manufactured - Others Manufactured - Others Growth | 828 | 940.61 | 572 | 494 | 613 |
Manufactured - Jaundice Treatment Device Manufactured - Jaundice Treatment Device Growth | 787 | 653.94 | 770 | 735 | 412 |
Other Other Growth | 595 | 574.5 | 900 | 1,077 | 707 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 6,535 | 2,901 | 5,808 | 9,919 | 8,936 | 804.89 |
Total Debt Total Debt Growth | 3,259 | 236.47 | 179.7 | 594.5 | 1,967 | 453.81 |
Net Cash (Debt) Net Cash Growth | 3,276 | 2,664 | 5,628 | 9,324 | 6,969 | 351.08 |
Net Cash Growth | -17.18% | -52.66% | -39.64% | 33.80% | 1884.92% | -61.19% |
Net Cash Per Share Net Cash Per Share Growth | 132.38 | 107.29 | 245.67 | 404.65 | 393.12 | 21.22 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 683.64 | -2,168 | 2,439 | 1,737 | -746.59 | -645.34 |
Capital Expenditures CapEx Growth | -247.25 | -184 | -5,923 | -220.11 | -156.58 | -70.67 |
Free Cash Flow Free Cash Flow Growth | 436.39 | -2,352 | -3,484 | 1,517 | -903.18 | -716.02 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 23.69% | 24.91% | 26.17% | 25.85% | 24.46% | 26.20% |
Operating Margin | -5.56% | -6.41% | 1.54% | 1.33% | 3.81% | 7.76% |
Pretax Margin | -5.08% | -6.27% | 4.74% | 2.85% | -19.35% | 8.95% |
Profit Margin | -2.78% | -4.09% | 4.18% | 3.79% | -18.79% | 9.03% |
FCF Margin | 2.67% | -13.76% | -17.20% | 7.12% | -3.77% | -3.49% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 45.30 | 62.01 | - | - |
P/FCF Ratio | 28.40 | - | - | 32.96 | - | - |
PS Ratio | 0.76 | 1.44 | 1.90 | 2.35 | 2.11 | - |